dibenzocycloheptenes

Preferred Label : dibenzocycloheptenes;

MeSH definition : A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC).;

Is substance : O;

Détails

Origin ID

D003986;

UMLS CUI

C0012032;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Dibenzocycloheptene (substance) [SNOMED CT concept]
Record concept(s)
- dibenzocycloheptenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 3-chloro-N,N-dimethylspiro-(5H-dibenzo(a,d)cycloheptene-5,1' cyclohex-2'-ene)-4'amine 2 [MeSH Supplementary Concept]
- 3-fluoro-10,5-(iminomethano)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene [MeSH Supplementary Concept]
- 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine [MeSH Supplementary Concept]
- 5-(2-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylamino)propyl)-5-(1H-tetrazol-5-yl)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene-2,8-dicarboxylic acid bisdimethylamide [MeSH Supplementary Concept]
- 5-(N-piperidino)-10,11-dihydro-5H-dibenzocycloheptene [MeSH Supplementary Concept]
- 5-dimethylaminopropylidenemethyldibenzocycloheptene [MeSH Supplementary Concept]
- 5H-dibenzo(a,d)cycloheptene-10,11-oxide [MeSH Supplementary Concept]
- A 23887 [MeSH Supplementary Concept]
- AR-C118925 [MeSH Supplementary Concept]
- Asenapine [MeSH Supplementary Concept]
- BS 7564 [MeSH Supplementary Concept]
- CP 117227 [MeSH Supplementary Concept]
- MK 940 [MeSH Supplementary Concept]
- N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-delta 5,alpha-propylamine N-oxide [MeSH Supplementary Concept]
- N-(8-methoxy-10,11-dihydro-5H-dibenzo(a,d)cycloheptene-10-ylmethyl)butyramide [MeSH Supplementary Concept]
- N-(8-methoxy-10,11-dihydro-5H-dibenzo(a,d)cycloheptene-10-ylmethyl)propionamide [MeSH Supplementary Concept]
- SC 27741 [MeSH Supplementary Concept]
- SC 28025 [MeSH Supplementary Concept]
- amineptin [MeSH Supplementary Concept]
- amurensin G [MeSH Supplementary Concept]
- butriptyline [MeSH Supplementary Concept]
- cyheptamide [MeSH Supplementary Concept]
- cytenamide [MeSH Supplementary Concept]
- dalesconol C [MeSH Supplementary Concept]
- demexiptiline [MeSH Supplementary Concept]
- dexclamol [MeSH Supplementary Concept]
- dibenzocycloheptadiene [MeSH Supplementary Concept]
- dibenzocycloheptatriene [MeSH Supplementary Concept]
- dibenzosuberanylpiperazine [MeSH Supplementary Concept]
- dibenzsuberone [MeSH Supplementary Concept]
- faveline methyl ether [MeSH Supplementary Concept]
- lonafarnib [MeSH Supplementary Concept]
- noxiptilin [MeSH Supplementary Concept]
- octriptyline phosphate [MeSH Supplementary Concept]
- piroheptine [MeSH Supplementary Concept]
- ro 68-3400 [MeSH Supplementary Concept]
- ro 8-1998 [MeSH Supplementary Concept]
- skepinone-L [MeSH Supplementary Concept]
- wy 41770 [MeSH Supplementary Concept]
- zosuquidar trihydrochloride [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients